Physician profile
German Newall
NPI 1588732671
$30,622.44
in general payments reported to CMS, 2019-2025
14 companies · $747 in 2025
The $747 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $24.34 · 2021: $1,191 · 2022: $306 · 2023: $675 · 2024: $1,001 · 2025: $747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,423.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $26,804.38 | 2019-2022 | |
| Sientra, INC. | $989.47 | 2019-2022 | |
| Motiva USA, LLC | $832.10 | 2024-2025 | |
| Revance Therapeutics, INC. | $641.31 | 2024 | Daxxify |
| Integra Lifesciences Corporation | $581.84 | 2023-2024 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Mentor Worldwide LLC | $262.03 | 2021-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Pacira Pharmaceuticals Incorporated | $153.14 | 2019-2025 | Exparel |
| Davol INC. | $101.78 | 2021 | |
| Abbvie INC. | $68.55 | 2025 | |
| Ethicon US, LLC | $55.96 | 2022-2025 | Dermabond Prineo, Ethicon, Monocryl |
| Merz North America, INC. | $43.66 | 2019 | |
| Acacia Pharma INC | $39.26 | 2022 | |
| Medtronic, INC. | $32.72 | 2025 | V-Loc 180 |
| Eagle Pharmaceuticals, INC. | $16.24 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw German Newall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.